Navigation Links
Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
Date:3/28/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...KLIN, Mass., Nov. 26 PLC...d today that it has received full approval from th...U.S. pivotal trial to study the effectiveness of t... therapy in the prevention of Contrast-Induced Nep...LC,s request to expand their investigation from th...
(Date:11/25/2008)...re-FirstCall/ -- Poniard,Pharmaceuticals, Inc. (N...ed on,innovative oncology therapies, announced to...ves for its preclinical research programs in order...he clinical development of picoplatin,its lead p...rcialization of,picoplatin in the treatment of sm...
(Date:11/24/2008)...no,s Pizza (NYSE: DPZ ), the,recognized world l...ugh for,the kids of St. Jude Children,s Research ...g campaign. Domino,s customers will have the oppor... benefit the children of St. Jude.,Donations can ...ing online at, www.dominos.com . The campaign beg...
(Date:11/24/2008)...l/ -- Schering-Plough Corporation (NYSE: SGP ) t...ctive adenosine2a receptor antagonist, met the pri...patients suffering from moderate to severe Parkins...bnormal involuntary movements (dyskinesias). The ...s 2008 R&D Update meeting being hosted for ana...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 2Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 4FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008 6188 1FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008 6188 2New cardiovascular score developed to improve heart attack and stroke detection 22648 1New cardiovascular score developed to improve heart attack and stroke detection 22648 23rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide Inc 22643 13rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide Inc 22643 2Heart Disease and Diabetes Finally Meet Their Match With Delicious New Snack Bars From WatchDog Nutrition 28TM 29 22638 1Heart Disease and Diabetes Finally Meet Their Match With Delicious New Snack Bars From WatchDog Nutrition 28TM 29 22638 2
...cified subset analyses of progression-free surviva...ate a reduction in,relative risk of disease progre...alyses included prior Taxotere use,geographies, a...une 04, 2007 /PRNewswire-FirstCall/ -- Pharmion,Co...resentation of,additional data from the double-bli...
...., June 04, 2007 /PRNewswire-FirstCall/ -- Boston,...ion of an article,in the Journal of of Cardiology ...hich evaluates the Company,s second-generation,TAX...em. The,article in the April 24 edition of JACC co...bailout rate of the TAXUS Liberte Stent,system com...
Other Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4
(Date:12/1/2008)...y prevent cognitive decline in some, study says ,...der adults who exercise regularly have increased b...n, a new study shows. , The University of North...nday at the Radiological Society of North America ...n other studies that exercise prevents cognitive d...
(Date:12/1/2008)...stress disorder (PTSD) affects as many as one in f...ience like rape, assault, war or terrorism. It has...n up survivors, families. , There is no broadly...eveloping the disorder, but thanks to a Tel Aviv U...g PTSD may be just around the corner. , Prof. Jo...
(Date:12/1/2008)...ec. 1 Medication therapy managemen...omplished professionals to its,advisory board. ,...nclude Martin Makary, M.D.;,Michael Burcham; and ...f,advisors that has helped PharmMD launch and hon...edication error, misuse, overuse and abuse. MTM i...
(Date:12/1/2008)...Newswire-USNewswire/ -- Condell Health Network, pa...bed hospital in Libertyville - after voluntarily d...edicaid payments - has agreed without litigation t...36 million as a result of filing false claims for ...S. Attorney for the Northern District of Illinois....
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:PharmMD Expands Advisory Board 2Health News:Condell Health Network and Medical Center to Pay $36 Million Settlement After Self-Reporting Possible Health-Care Fraud 2
...ld observes Women's Day to celebrate the emancipat...a special reason to rejoice//. In addition to the ...ditional laurel of becoming Nepal's only graduate ...four, Rashmila, now 24, was worshipped and revered...
...a expecting at least 100,000 medical tourists in t...try is in the pink of its health//. Foreigners ar...nd cosmetic surgery, facial surgery, dental treatm...ee replacement, ophthalmology, voice therapy and o...
...e materials that grab stem cells and spur their gr...ries. Linda Griffith and her colleagues// at MIT h... could help cells survive the harsh transplant env.... Scientists are now testing the material in anima...
...ade long study has come out in support of the adag...h. Dutch researchers examined around 1500 men// wh...hey have concluded that while drinking less than a...r rates of death from cardiovascular causes and ot...
Other Medicine News:Health News:Nepal Gets Its First Graduate Goddess 2Health News:Kerala Sees Medical Tourism Soaring 2Health News:Healing Bone With Stem Cells 2
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician.
AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more.
Containing more than 600 full drug monographs, plus abbreviated monographs for combination drugs, orphan drugs and AIDS drugs in development, A to Z Drug Facts provides up-to-date information on more
Provides instant access to reliable information on herbs, minerals, vitamins, amino acids, probiotics, enzymes, over-the-counter hormones, and other dietary supplements commonly used by consumers.
Medicine Products: